A return to some drug pricing normalcy
Ben LinkNADAC, Medicaid, Generic, cincacalcet, CBO, Brand drugs, List prices, Rebates, Pfizer, Upjohn, Viatris, Depo-Provera, WAC, Gamunex-C, Part D, ADHD, dexmethylphenidate, Methylphenidate, lamotrigine, Paliperidone, clozapine, tizanidine, dosage forms, polyethylene glycol
Drugmakers break record for most January list price increases in a decade
Ben LinkNADAC, Medicaid, Generic, Semglee, Basaglar, Albendazole, Part D, Eliquis, Grassley, Wyden, Insulin, Mycophenolic Acid, Dalfampridine, clobazam, cincacalcet, Mark Cuban, acetaminophen, lansoprazole ODT, lamotrigine, Clonidine, atomoxetine
It's not just insulin: Comparing the cost of diabetes treatment in Canada versus the U.S.
Ben LinkWAC, List prices, Medicaid, Insulin, Diabetes, Canada, International pricing, Eliquis, Ohio, Eli Lilly, Pradaxa, Xarelto
New dashboard launched to track brand drug price increases
May your holidays be filled with generic drug deflation!
Gobble, Gobble — generic drug pricing deflation is served
Did generic drugs party too hard?
Generic drug prices take a tumble
Ben LinkNADAC, Medicaid, Generic, COVID, Methylphenidate, Concerta, ADHD, Zoloft, sertraline, Adderall, Dextroamphetamine, dexamethasone
46brooklyn releases dashboard comparing drug prices in U.S. and Australia; identifies $38 billion in annual U.S. overspending
